TP53BP2 and cancer: Given the current interest in inhibiting YAP/TAZ activity for cancer therapy58, inhibitors of the ASPP2/PP1 complex, which would increase YAP/TAZ inhibitory phosphorylation, might prove an interesting therapeutic avenue.